Effects of X Box Kinect 360 in Alzheimer's Disease
ConditionAlzheimer s Disease
Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age50-85
SponsorZiauddin University
About this trial
Alzheimer's disease (AD) is a progressive neurodegenerative disorder and the most common cause of dementia that accounting for 60% to 80% of all cases (Better, et al., 2023). According to world health organization (WHO), more than 55 million people globally live with dementia, and this number is expected to rise to 78 million by 2023 and 139 million by 2050 (WHO, 2021).
Eligibility criteria
Qualifiers
Alzheimer's disease of age between 50-85 years.
Diagnosed AD stage Mild to Moderate.
Disqualifiers
Undiagnosed AD patients.
Mental or neurological conditions like schizophrenia, Parkinson's, or stroke.
Trial design
Treatments tested in this trial
- 3D Kinect based game
- Conventional therapy group
Treatment groups
38 Participants
are divided into 2 treatment groupsSponsors and collaborators
Source ClinicalTrials.gov